Caraco Pharmaceutical Laboratories Ltd. said it has reached an agreement with Hexal-Pharma GmbH, of Munich, Germany, to acquire from its U.S. affiliate, Hexal Pharmaceuticals Inc., the ingredients and manufacturing processes for at least two of its generic drugs.
Terms weren't disclosed.
